Massa Plica Vocalis

01Pathophysiology

Vocal cord masses arise from the layered microanatomy of the vocal fold. The vocal fold is composed of the epithelium, the superficial lamina propria (Reinke's space), the deeper layers of the lamina propria (vocal ligament), and the vocalis muscle. Normal phonation depends on the pliability of the superficial lamina propria, which allows the "mucosal wave" to propagate during vibration. Any lesion that alters the mass, tension, or regularity of this mucosal cover will disrupt vibration and produce dysphonia.

Vocal cord nodules develop from chronic mechanical stress at the junction of the anterior one-third and posterior two-thirds of the membranous vocal fold, the point of maximal vibratory contact. Repeated collision causes localized edema, then progressive fibrosis of the superficial lamina propria. Because the trauma is bilateral and symmetric, nodules are characteristically bilateral. This is why they are strongly associated with voice overuse in singers, teachers, and young children who shout frequently.

Vocal cord polyps result from a similar phonotraumatic mechanism but tend to follow an acute vocal insult (a single episode of intense voice abuse or a hemorrhagic event within Reinke's space). Unlike nodules, polyps are usually unilateral and arise from a localized vascular injury that produces edema, fibrin deposition, and sometimes thrombosis. Smoking potentiates polyp formation by increasing vascular fragility in the lamina propria.

Reinke's edema (polypoid corditis) is a diffuse, bilateral accumulation of gelatinous fluid within Reinke's space. It is almost exclusively seen in chronic smokers, and often in combination with laryngopharyngeal reflux (LPR). The diffuse swelling of both vocal folds lowers the fundamental frequency of the voice, producing a characteristically deep, husky voice quality, particularly noticeable in women.

Laryngeal papillomas are caused by HPV types 6 and 11 (the same low-risk strains that cause anogenital warts). In children, vertical transmission from the birth canal leads to juvenile-onset recurrent respiratory papillomatosis (RRP), which typically presents before age 5 with progressive hoarseness, stridor, and potential airway compromise. In adults, the disease is usually less aggressive and often presents with isolated hoarseness. Papillomas are exophytic, cauliflower-like growths that can seed throughout the airway. Despite being histologically benign, they are notorious for recurrence after excision.

Contact granulomas form on the vocal process of the arytenoid cartilage, the posterior portion of the vocal fold where the cartilaginous framework is covered only by thin mucosa. Chronic irritation from GERD/LPR, endotracheal intubation, or habitual throat clearing causes mucosal ulceration followed by exuberant granulation tissue formation. The location (posterior glottis, overlying the arytenoid) is the key anatomic discriminator from nodules and polyps, which occur on the membranous fold.

Laryngeal squamous cell carcinoma accounts for the vast majority of malignant vocal cord masses. The synergistic carcinogenic effects of tobacco and alcohol drive squamous metaplasia, dysplasia, and eventual invasive carcinoma. Precursor lesions such as leukoplakia (white mucosal patches) and erythroplakia (red patches, which carry a higher malignant potential) may be seen on laryngoscopy. Glottic carcinoma (arising from the true vocal folds) presents early with hoarseness because even a small lesion disrupts vibration. In contrast, supraglottic carcinoma presents later with dysphagia, muffled voice, referred otalgia, or neck mass because the supraglottic region is less sensitive to small changes in mass.

02Classification and Clinical Manifestation

03Diagnostic Workup

The evaluation of any vocal cord mass begins with a thorough history. The examiner will look for duration and progression of hoarseness, voice use patterns, smoking and alcohol history, GERD symptoms, history of intubation, and any associated symptoms such as dysphagia, otalgia, weight loss, or hemoptysis. Any patient with hoarseness lasting more than 2 weeks should undergo laryngoscopy to rule out malignancy. This is one of the most tested principles in this topic.

Flexible fiberoptic nasopharyngolaryngoscopy is the best initial test. It is performed in the outpatient setting and allows direct visualization of the vocal folds. The examiner can assess the color, surface texture, size, location, and number of lesions, as well as vocal fold mobility during phonation. Immobility or fixation of one vocal fold raises concern for invasion of the cricoarytenoid joint or the recurrent laryngeal nerve by a malignant process.

Videostroboscopy is the most important functional assessment tool. Stroboscopic light allows slow-motion visualization of the mucosal wave. In benign superficial lesions (nodules, polyps), the mucosal wave is typically present but may be dampened. In malignant or deeply infiltrative lesions, the mucosal wave is absent or markedly reduced because the tumor tethers the mucosa to the deeper structures, eliminating the pliability of Reinke's space. This finding is a critical discriminator between benign and malignant pathology.

Biopsy is mandatory for any lesion that is suspicious for malignancy. Indications include unilateral vocal fold lesions in a smoker, leukoplakia, erythroplakia, an irregularly surfaced or exophytic mass, or any lesion failing to respond to conservative management. Biopsy is typically performed via direct microlaryngoscopy under general anesthesia, which also allows therapeutic excision of benign lesions. Histopathology is the gold standard for definitive diagnosis.

For confirmed malignancy, CT of the neck with contrast is the primary imaging modality for staging. It assesses depth of invasion, cartilage involvement (particularly the thyroid and cricoid cartilages), paraglottic and pre-epiglottic space invasion, and cervical lymph node metastasis. A chest X-ray or CT chest is obtained to evaluate for pulmonary metastases and to screen for a synchronous second primary malignancy, which occurs with notable frequency due to field cancerization from shared tobacco exposure.

04Management and Treatment

Benign lesions are managed with a conservative-first approach. The cornerstone of treatment for vocal cord nodules is voice therapy with a speech-language pathologist. Voice therapy addresses the underlying phonotraumatic behavior that caused the nodules. If the patient adheres to therapy and proper vocal hygiene (hydration, avoidance of irritants, rest), nodules frequently resolve or improve significantly within 6 to 12 weeks. Surgery is reserved for nodules that are fibrotic and refractory to therapy. It is critical to understand that excision without addressing the vocal behavior will result in recurrence.

For vocal cord polyps, voice therapy alone is less likely to produce resolution because polyps often contain organized fibrin, vascular proliferation, or hemorrhage. Microlaryngeal surgery (phonosurgery) is the definitive treatment. This is performed under general anesthesia with direct laryngoscopy and microsurgical instruments, carefully excising the polyp while preserving the underlying lamina propria to protect the mucosal wave.

Reinke's edema will not resolve without smoking cessation. This is a non-negotiable prerequisite. Anti-reflux therapy with proton pump inhibitors (e.g., omeprazole 20-40 mg daily) is added if LPR is suspected. If the voice remains unacceptable after smoking cessation and medical optimization, surgical reduction via microflap technique can restore a more normal vocal fold contour.

Recurrent respiratory papillomatosis requires repeated debulking procedures because there is no cure. The virus persists in adjacent-appearing normal mucosa, driving recurrences. The goal of surgery is to maintain a safe airway and acceptable voice without causing scarring of the vocal folds. CO2 laser ablation and microdebrider techniques are standard. Tracheostomy is avoided whenever possible because the surgical stoma creates a new mucosal surface where papillomas can seed, potentially extending the disease into the lower airway. Adjuvant therapies such as intralesional cidofovir or systemic bevacizumab (anti-VEGF) are considered in cases with aggressive, frequently recurring disease.

Contact granulomas are managed primarily with anti-reflux therapy (high-dose PPI, twice daily dosing for 3 to 6 months), voice therapy to reduce forceful glottal closure, and cessation of throat clearing. Surgical excision carries a high recurrence rate (up to 70%) and is therefore reserved for cases where airway compromise is present or biopsy is needed to exclude granular cell tumor or other pathology.

For laryngeal carcinoma, early-stage glottic disease (T1-T2, N0) has excellent cure rates exceeding 85-90% with either radiation therapy or transoral laser microsurgery. Both approaches achieve comparable oncologic outcomes; the choice is individualized based on tumor volume, patient preference, and voice quality considerations. Radiation is typically delivered at 60 to 66 Gy in 2 Gy fractions over 6 to 7 weeks.

Advanced-stage disease (T3-T4a or node-positive) is managed with concurrent chemoradiation using the organ-preservation protocol, which avoids total laryngectomy. The standard chemotherapy agent is cisplatin at $100mg\mathrm{/}{m}^{2}100\backslash \; mg/m^2$ administered intravenously every 3 weeks during the radiation course. Total laryngectomy with permanent tracheostomy is reserved for patients who fail organ preservation, have T4a disease with thyroid cartilage destruction through and through, or who are not candidates for chemoradiation. Supraglottic cancers have a higher propensity for cervical lymph node metastasis due to the rich lymphatic drainage of the supraglottic region, so neck dissection or elective nodal radiation is routinely incorporated.

05Differential Diagnosis and Distractors

06Traps and High-Yield Pearls

The most common way students get questions about vocal cord masses wrong is by failing to appreciate the significance of hoarseness lasting more than 2 weeks in a patient with risk factors for malignancy. A vignette that describes a 55-year-old smoker with 3 weeks of progressive hoarseness is not asking about voice rest or reflux therapy. The answer is laryngoscopy. Students who jump to "trial of PPI" or "voice therapy" without first visualizing the larynx will miss the diagnosis of carcinoma. The rule is simple: hoarseness beyond 2 weeks requires direct visualization.

A second trap involves confusing bilateral nodules with a unilateral polyp. Both are phonotraumatic, but the management diverges: nodules respond to voice therapy, whereas polyps usually require surgical excision. If the vignette says the lesion is bilateral and symmetric, the answer is voice therapy first. If it says unilateral, think polyp and plan for surgery.

Students also frequently miss the connection between laryngeal papillomatosis and HPV 6/11. The exam loves to present a child with progressive hoarseness and stridor, born via vaginal delivery to a mother with a history of condylomata. The answer is juvenile-onset RRP. The corollary pearl is that tracheostomy is avoided in these patients because of the risk of distal airway seeding.

Another tested concept is the location of contact granulomas on the vocal process of the arytenoid, not on the membranous vocal fold. This posterior location, combined with a history of intubation or chronic GERD, should immediately point to contact granuloma rather than a nodule or polyp.

Finally, for laryngeal carcinoma, students must recognize the distinction between glottic and supraglottic primaries. Glottic tumors present early (hoarseness) and metastasize to lymph nodes late because the true vocal fold has minimal lymphatic drainage. Supraglottic tumors present late (dysphagia, otalgia, neck mass) and metastasize early because the supraglottic region is richly supplied with lymphatics. This anatomic logic dictates both the clinical presentation and the staging workup, and it is tested repeatedly.